Global Pulmonary Drug Delivery Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
Page: 119
Published Date: 19 Feb 2021
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Pulmonary Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pulmonary Drug Delivery Devices size is estimated to be xx million in 2021 from USD 2917.7 million in 2020, with a change of XX% between 2020 and 2021. The global Pulmonary Drug Delivery Devices market size is expected to grow at a CAGR of 4.0% for the next five years.
Market segmentation
Pulmonary Drug Delivery Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Market segment by Application can be divided into
Asthma
COPD
Cystic Fibrosis
Other
The key market players for global Pulmonary Drug Delivery Devices market are listed below:
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Devices, with price, sales, revenue and global market share of Pulmonary Drug Delivery Devices from 2019 to 2021.
Chapter 3, the Pulmonary Drug Delivery Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pulmonary Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pulmonary Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pulmonary Drug Delivery Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pulmonary Drug Delivery Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Dry Powder Inhaler
1.2.3 Metered Dose Inhaler
1.2.4 Nebulizer
1.3 Market Analysis by Application
1.3.1 Overview: Global Pulmonary Drug Delivery Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Asthma
1.3.3 COPD
1.3.4 Cystic Fibrosis
1.3.5 Other
1.4 Global Pulmonary Drug Delivery Devices Market Size & Forecast
1.4.1 Global Pulmonary Drug Delivery Devices Sales in Value (2016-2026))
1.4.2 Global Pulmonary Drug Delivery Devices Sales in Volume (2016-2026)
1.4.3 Global Pulmonary Drug Delivery Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Pulmonary Drug Delivery Devices Production Capacity Analysis
1.5.1 Global Pulmonary Drug Delivery Devices Total Production Capacity (2016-2026)
1.5.2 Global Pulmonary Drug Delivery Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pulmonary Drug Delivery Devices Market Drivers
1.6.2 Pulmonary Drug Delivery Devices Market Restraints
1.6.3 Pulmonary Drug Delivery Devices Trends Analysis
2.1 Boehringer Ingelheim GmbH
2.1.1 Boehringer Ingelheim GmbH Details
2.1.2 Boehringer Ingelheim GmbH Major Business
2.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
2.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Pulmonary Drug Delivery Devices Product and Services
2.2.4 Novartis AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
2.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Pulmonary Drug Delivery Devices Product and Services
2.4.4 AstraZeneca Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Teva Pharmaceutical Industries
2.5.1 Teva Pharmaceutical Industries Details
2.5.2 Teva Pharmaceutical Industries Major Business
2.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
2.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Pulmonary Drug Delivery Devices Product and Services
2.6.4 Merck Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 MannKind
2.7.1 MannKind Details
2.7.2 MannKind Major Business
2.7.3 MannKind Pulmonary Drug Delivery Devices Product and Services
2.7.4 MannKind Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
2.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Mylan N.V
2.9.1 Mylan N.V Details
2.9.2 Mylan N.V Major Business
2.9.3 Mylan N.V Pulmonary Drug Delivery Devices Product and Services
2.9.4 Mylan N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Omron Corp
2.10.1 Omron Corp Details
2.10.2 Omron Corp Major Business
2.10.3 Omron Corp Pulmonary Drug Delivery Devices Product and Services
2.10.4 Omron Corp Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 F. Hoffmann-La Roche
2.11.1 F. Hoffmann-La Roche Details
2.11.2 F. Hoffmann-La Roche Major Business
2.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
2.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 3M Healthcare
2.12.1 3M Healthcare Details
2.12.2 3M Healthcare Major Business
2.12.3 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
2.12.4 3M Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Sunovion Pharmaceuticals
2.13.1 Sunovion Pharmaceuticals Details
2.13.2 Sunovion Pharmaceuticals Major Business
2.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
2.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Koninklijke Philips N.V
2.14.1 Koninklijke Philips N.V Details
2.14.2 Koninklijke Philips N.V Major Business
2.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
2.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Gerresheimer AG
2.15.1 Gerresheimer AG Details
2.15.2 Gerresheimer AG Major Business
2.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
2.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Bespak
2.16.1 Bespak Details
2.16.2 Bespak Major Business
2.16.3 Bespak Pulmonary Drug Delivery Devices Product and Services
2.16.4 Bespak Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 AptarGroup
2.17.1 AptarGroup Details
2.17.2 AptarGroup Major Business
2.17.3 AptarGroup Pulmonary Drug Delivery Devices Product and Services
2.17.4 AptarGroup Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 SHL Group
2.18.1 SHL Group Details
2.18.2 SHL Group Major Business
2.18.3 SHL Group Pulmonary Drug Delivery Devices Product and Services
2.18.4 SHL Group Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Nypro Healthcare
2.19.1 Nypro Healthcare Details
2.19.2 Nypro Healthcare Major Business
2.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
2.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Hovione
2.20.1 Hovione Details
2.20.2 Hovione Major Business
2.20.3 Hovione Pulmonary Drug Delivery Devices Product and Services
2.20.4 Hovione Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Chiesi Farmaceutici S.P.A
2.21.1 Chiesi Farmaceutici S.P.A Details
2.21.2 Chiesi Farmaceutici S.P.A Major Business
2.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
2.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pulmonary Drug Delivery Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pulmonary Drug Delivery Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Pulmonary Drug Delivery Devices Manufacturer Market Share
3.4.2 Top 6 Pulmonary Drug Delivery Devices Manufacturer Market Share
3.5 Global Pulmonary Drug Delivery Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pulmonary Drug Delivery Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4.1 Global Pulmonary Drug Delivery Devices Market Size by Region
4.1.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Pulmonary Drug Delivery Devices Revenue by Region (2016-2026)
4.2 North America Pulmonary Drug Delivery Devices Revenue (2016-2026)
4.3 Europe Pulmonary Drug Delivery Devices Revenue (2016-2026)
4.4 Asia-Pacific Pulmonary Drug Delivery Devices Revenue (2016-2026)
4.5 South America Pulmonary Drug Delivery Devices Revenue (2016-2026)
4.6 Middle East and Africa Pulmonary Drug Delivery Devices Revenue (2016-2026)
5.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Type (2016-2026)
5.2 Global Pulmonary Drug Delivery Devices Revenue by Type (2016-2026)
5.3 Global Pulmonary Drug Delivery Devices Price by Type (2016-2026)
6.1 Global Pulmonary Drug Delivery Devices Sales in Volume by Application (2016-2026)
6.2 Global Pulmonary Drug Delivery Devices Revenue by Application (2016-2026)
6.3 Global Pulmonary Drug Delivery Devices Price by Application (2016-2026)
7.1 North America Pulmonary Drug Delivery Devices Sales by Type (2016-2026)
7.2 North America Pulmonary Drug Delivery Devices Sales by Application (2016-2026)
7.3 North America Pulmonary Drug Delivery Devices Market Size by Country
7.3.1 North America Pulmonary Drug Delivery Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Pulmonary Drug Delivery Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8.1 Europe Pulmonary Drug Delivery Devices Sales by Type (2016-2026)
8.2 Europe Pulmonary Drug Delivery Devices Sales by Application (2016-2026)
8.3 Europe Pulmonary Drug Delivery Devices Market Size by Country
8.3.1 Europe Pulmonary Drug Delivery Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Pulmonary Drug Delivery Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Pulmonary Drug Delivery Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Pulmonary Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pulmonary Drug Delivery Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10.1 South America Pulmonary Drug Delivery Devices Sales by Type (2016-2026)
10.2 South America Pulmonary Drug Delivery Devices Sales by Application (2016-2026)
10.3 South America Pulmonary Drug Delivery Devices Market Size by Country
10.3.1 South America Pulmonary Drug Delivery Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Pulmonary Drug Delivery Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Pulmonary Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pulmonary Drug Delivery Devices Typical Distributors
12.3 Pulmonary Drug Delivery Devices Typical Customers
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pulmonary Drug Delivery Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pulmonary Drug Delivery Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim GmbH Major Business
Table 5. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
Table 6. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis AG Major Business
Table 9. Novartis AG Pulmonary Drug Delivery Devices Product and Services
Table 10. Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
Table 14. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Pulmonary Drug Delivery Devices Product and Services
Table 18. AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 20. Teva Pharmaceutical Industries Major Business
Table 21. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
Table 22. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Pulmonary Drug Delivery Devices Product and Services
Table 26. Merck Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. MannKind Basic Information, Manufacturing Base and Competitors
Table 28. MannKind Major Business
Table 29. MannKind Pulmonary Drug Delivery Devices Product and Services
Table 30. MannKind Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Major Business
Table 33. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
Table 34. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 36. Mylan N.V Major Business
Table 37. Mylan N.V Pulmonary Drug Delivery Devices Product and Services
Table 38. Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Omron Corp Basic Information, Manufacturing Base and Competitors
Table 40. Omron Corp Major Business
Table 41. Omron Corp Pulmonary Drug Delivery Devices Product and Services
Table 42. Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 44. F. Hoffmann-La Roche Major Business
Table 45. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
Table 46. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. 3M Healthcare Basic Information, Manufacturing Base and Competitors
Table 48. 3M Healthcare Major Business
Table 49. 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 50. 3M Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Sunovion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Sunovion Pharmaceuticals Major Business
Table 53. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
Table 54. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Koninklijke Philips N.V Basic Information, Manufacturing Base and Competitors
Table 56. Koninklijke Philips N.V Major Business
Table 57. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
Table 58. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 60. Gerresheimer AG Major Business
Table 61. Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
Table 62. Gerresheimer AG Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Bespak Basic Information, Manufacturing Base and Competitors
Table 64. Bespak Major Business
Table 65. Bespak Pulmonary Drug Delivery Devices Product and Services
Table 66. Bespak Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. AptarGroup Basic Information, Manufacturing Base and Competitors
Table 68. AptarGroup Major Business
Table 69. AptarGroup Pulmonary Drug Delivery Devices Product and Services
Table 70. AptarGroup Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. SHL Group Basic Information, Manufacturing Base and Competitors
Table 72. SHL Group Major Business
Table 73. SHL Group Pulmonary Drug Delivery Devices Product and Services
Table 74. SHL Group Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Nypro Healthcare Basic Information, Manufacturing Base and Competitors
Table 76. Nypro Healthcare Major Business
Table 77. Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 78. Nypro Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Hovione Basic Information, Manufacturing Base and Competitors
Table 80. Hovione Major Business
Table 81. Hovione Pulmonary Drug Delivery Devices Product and Services
Table 82. Hovione Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Chiesi Farmaceutici S.P.A Basic Information, Manufacturing Base and Competitors
Table 84. Chiesi Farmaceutici S.P.A Major Business
Table 85. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
Table 86. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Global Pulmonary Drug Delivery Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 88. Global Pulmonary Drug Delivery Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 89. Market Position of Manufacturers in Pulmonary Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 90. Global Pulmonary Drug Delivery Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 91. Head Office and Pulmonary Drug Delivery Devices Production Site of Key Manufacturer
Table 92. Pulmonary Drug Delivery Devices New Entrant and Capacity Expansion Plans
Table 93. Pulmonary Drug Delivery Devices Mergers & Acquisitions in the Past Five Years
Table 94. Global Pulmonary Drug Delivery Devices Sales by Region (2016-2021e) & (K Units)
Table 95. Global Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (K Units)
Table 96. Global Pulmonary Drug Delivery Devices Revenue by Region (2016-2021e) & (USD Million)
Table 97. Global Pulmonary Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)
Table 98. Global Pulmonary Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 99. Global Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 100. Global Pulmonary Drug Delivery Devices Revenue by Type (2016-2021e) & (USD Million)
Table 101. Global Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
Table 102. Global Pulmonary Drug Delivery Devices Price by Type (2016-2021e) & (USD/Unit)
Table 103. Global Pulmonary Drug Delivery Devices Price by Type (2021-2026) & (USD/Unit)
Table 104. Global Pulmonary Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 105. Global Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 106. Global Pulmonary Drug Delivery Devices Revenue by Application (2016-2021e) & (USD Million)
Table 107. Global Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
Table 108. Global Pulmonary Drug Delivery Devices Price by Application (2016-2021e) & (USD/Unit)
Table 109. Global Pulmonary Drug Delivery Devices Price by Application (2021-2026) & (USD/Unit)
Table 110. North America Pulmonary Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 111. North America Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 112. North America Pulmonary Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 113. North America Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 114. North America Pulmonary Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 115. North America Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 116. North America Pulmonary Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 117. North America Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 118. Europe Pulmonary Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 119. Europe Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 120. Europe Pulmonary Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 121. Europe Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 122. Europe Pulmonary Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 123. Europe Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 124. Europe Pulmonary Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 125. Europe Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 126. Asia-Pacific Pulmonary Drug Delivery Devices Sales by Region (2016-2021e) & (K Units)
Table 127. Asia-Pacific Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (K Units)
Table 128. Asia-Pacific Pulmonary Drug Delivery Devices Revenue by Region (2016-2021e) & (USD Million)
Table 129. Asia-Pacific Pulmonary Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)
Table 130. Asia-Pacific Pulmonary Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 131. Asia-Pacific Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 132. Asia-Pacific Pulmonary Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 133. Asia-Pacific Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 134. South America Pulmonary Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 135. South America Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 136. South America Pulmonary Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 137. South America Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 138. South America Pulmonary Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 139. South America Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 140. South America Pulmonary Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 141. South America Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 142. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 143. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 144. Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 145. Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 146. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 147. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 148. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 149. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Pulmonary Drug Delivery Devices Typical Distributors
Table 153. Pulmonary Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Pulmonary Drug Delivery Devices Picture
Figure 2. Global Pulmonary Drug Delivery Devices Sales Market Share by Type in 2020
Figure 3. Dry Powder Inhaler
Figure 4. Metered Dose Inhaler
Figure 5. Nebulizer
Figure 6. Global Pulmonary Drug Delivery Devices Sales Market Share by Application in 2020
Figure 7. Asthma
Figure 8. COPD
Figure 9. Cystic Fibrosis
Figure 10. Other
Figure 11. Global Pulmonary Drug Delivery Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Pulmonary Drug Delivery Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Pulmonary Drug Delivery Devices Sales (2016-2026) & (K Units)
Figure 14. Global Pulmonary Drug Delivery Devices Price by Type (2016-2026) & (USD/Unit)
Figure 15. Global Pulmonary Drug Delivery Devices Production Capacity (2016-2026) & (K Units)
Figure 16. Global Pulmonary Drug Delivery Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Pulmonary Drug Delivery Devices Market Drivers
Figure 18. Pulmonary Drug Delivery Devices Market Restraints
Figure 19. Pulmonary Drug Delivery Devices Market Trends
Figure 20. Global Pulmonary Drug Delivery Devices Sales Market Share by Manufacturer in 2020
Figure 21. Global Pulmonary Drug Delivery Devices Revenue Market Share by Manufacturer in 2020
Figure 22. Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Pulmonary Drug Delivery Devices Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Pulmonary Drug Delivery Devices Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Pulmonary Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 26. Global Pulmonary Drug Delivery Devices Revenue Market Share by Region (2016-2026)
Figure 27. North America Pulmonary Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 28. Europe Pulmonary Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Pulmonary Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 30. South America Pulmonary Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Pulmonary Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 32. Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 33. Global Pulmonary Drug Delivery Devices Revenue Market Share by Type (2016-2026)
Figure 34. Global Pulmonary Drug Delivery Devices Price by Type (2016-2026) & (USD/Unit)
Figure 35. Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 36. Global Pulmonary Drug Delivery Devices Revenue Market Share by Application (2016-2026)
Figure 37. Global Pulmonary Drug Delivery Devices Price by Application (2016-2026) & (USD/Unit)
Figure 38. North America Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 39. North America Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 40. North America Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 41. North America Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 42. United States Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 46. Europe Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 47. Europe Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 48. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 49. Germany Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Pulmonary Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Pulmonary Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Pulmonary Drug Delivery Devices Revenue Market Share by Region (2016-2026)
Figure 58. China Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 65. South America Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 66. South America Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 67. South America Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Pulmonary Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Boehringer Ingelheim GmbH Novartis AG GlaxoSmithKline AstraZeneca Teva Pharmaceutical Industries Merck MannKind Bristol-Myers Squibb Mylan N.V Omron Corp F. Hoffmann-La Roche 3M Healthcare Sunovion Pharmaceuticals Koninklijke Philips N.V Gerresheimer AG Bespak AptarGroup SHL Group Nypro Healthcare Hovione Chiesi Farmaceutici S.P.A
Related Reports
04 Jan 2022
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
